UNIVERSAL HEALTH SERVICES-B (UHS) Stock Fundamental Analysis

NYSE:UHS • US9139031002

205.43 USD
-25.3 (-10.97%)
Last: Feb 26, 2026, 01:08 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

5

Overall UHS gets a fundamental rating of 5 out of 10. We evaluated UHS against 101 industry peers in the Health Care Providers & Services industry. UHS has an excellent profitability rating, but there are some minor concerns on its financial health. UHS is valued quite cheap, while showing a decent growth score. This is a good combination!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year UHS was profitable.
  • UHS had a positive operating cash flow in the past year.
  • UHS had positive earnings in 4 of the past 5 years.
  • Of the past 5 years UHS 4 years had a positive operating cash flow.
UHS Yearly Net Income VS EBIT VS OCF VS FCFUHS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

1.2 Ratios

  • UHS's Return On Assets of 8.96% is amongst the best of the industry. UHS outperforms 93.07% of its industry peers.
  • Looking at the Return On Equity, with a value of 19.18%, UHS belongs to the top of the industry, outperforming 87.13% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 12.33%, UHS belongs to the top of the industry, outperforming 87.13% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for UHS is in line with the industry average of 8.93%.
  • The 3 year average ROIC (8.28%) for UHS is below the current ROIC(12.33%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 8.96%
ROE 19.18%
ROIC 12.33%
ROA(3y)6.01%
ROA(5y)6.51%
ROE(3y)13.4%
ROE(5y)14.27%
ROIC(3y)8.28%
ROIC(5y)8.76%
UHS Yearly ROA, ROE, ROICUHS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • UHS has a Profit Margin of 8.09%. This is amongst the best in the industry. UHS outperforms 89.11% of its industry peers.
  • UHS's Profit Margin has been stable in the last couple of years.
  • UHS's Operating Margin of 11.47% is amongst the best of the industry. UHS outperforms 81.19% of its industry peers.
  • UHS's Operating Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 11.47%
PM (TTM) 8.09%
GM N/A
OM growth 3Y-0.49%
OM growth 5Y-0.12%
PM growth 3Y-2.68%
PM growth 5Y0.2%
GM growth 3YN/A
GM growth 5YN/A
UHS Yearly Profit, Operating, Gross MarginsUHS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), UHS is creating some value.
  • UHS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
UHS Yearly Shares OutstandingUHS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
UHS Yearly Total Debt VS Total AssetsUHS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B

2.2 Solvency

  • An Altman-Z score of 3.24 indicates that UHS is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of UHS (3.24) is better than 69.31% of its industry peers.
  • The Debt to FCF ratio of UHS is 4.84, which is a neutral value as it means it would take UHS, 4.84 years of fcf income to pay off all of its debts.
  • With a decent Debt to FCF ratio value of 4.84, UHS is doing good in the industry, outperforming 64.36% of the companies in the same industry.
  • A Debt/Equity ratio of 0.55 indicates that UHS is somewhat dependend on debt financing.
  • UHS has a better Debt to Equity ratio (0.55) than 61.39% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 4.84
Altman-Z 3.24
ROIC/WACC1.62
WACC7.62%
UHS Yearly LT Debt VS Equity VS FCFUHS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.3 Liquidity

  • A Current Ratio of 1.03 indicates that UHS should not have too much problems paying its short term obligations.
  • UHS has a worse Current ratio (1.03) than 69.31% of its industry peers.
  • A Quick Ratio of 0.96 indicates that UHS may have some problems paying its short term obligations.
  • UHS's Quick ratio of 0.96 is on the low side compared to the rest of the industry. UHS is outperformed by 65.35% of its industry peers.
Industry RankSector Rank
Current Ratio 1.03
Quick Ratio 0.96
UHS Yearly Current Assets VS Current LiabilitesUHS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • UHS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 30.77%, which is quite impressive.
  • Measured over the past years, UHS shows a quite strong growth in Earnings Per Share. The EPS has been growing by 14.35% on average per year.
EPS 1Y (TTM)30.77%
EPS 3Y29.98%
EPS 5Y14.35%
EPS Q2Q%19.51%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%9.05%

3.2 Future

  • Based on estimates for the next years, UHS will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.25% on average per year.
  • The Revenue is expected to grow by 3.51% on average over the next years.
EPS Next Y9.16%
EPS Next 2Y10.4%
EPS Next 3Y9.72%
EPS Next 5Y10.25%
Revenue Next Year4.96%
Revenue Next 2Y5.09%
Revenue Next 3Y3.5%
Revenue Next 5Y3.51%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
UHS Yearly Revenue VS EstimatesUHS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5B 10B 15B 20B
UHS Yearly EPS VS EstimatesUHS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10 20 30

More info and screens

Find the best growth stocksShow best growing peers

7

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 9.44 indicates a reasonable valuation of UHS.
  • Based on the Price/Earnings ratio, UHS is valued cheaply inside the industry as 90.10% of the companies are valued more expensively.
  • The average S&P500 Price/Earnings ratio is at 27.05. UHS is valued rather cheaply when compared to this.
  • With a Price/Forward Earnings ratio of 8.65, the valuation of UHS can be described as very reasonable.
  • UHS's Price/Forward Earnings ratio is rather cheap when compared to the industry. UHS is cheaper than 90.10% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 28.03. UHS is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 9.44
Fwd PE 8.65
UHS Price Earnings VS Forward Price EarningsUHS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, UHS is valued cheaply inside the industry as 83.17% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, UHS is valued a bit cheaper than the industry average as 77.23% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 13.26
EV/EBITDA 7.44
UHS Per share dataUHS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200 250

4.3 Compensation for Growth

  • UHS's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The decent profitability rating of UHS may justify a higher PE ratio.
PEG (NY)1.03
PEG (5Y)0.66
EPS Next 2Y10.4%
EPS Next 3Y9.72%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. Dividend

5.1 Amount

  • UHS has a yearly dividend return of 0.35%, which is pretty low.
  • Compared to an average industry Dividend Yield of 0.49, UHS pays a bit more dividend than its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.80, UHS's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.35%

5.2 History

  • On average, the dividend of UHS grows each year by 6.27%, which is quite nice.
  • UHS has paid a dividend for at least 10 years, which is a reliable track record.
  • UHS has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)6.27%
Div Incr Years0
Div Non Decr Years4
UHS Yearly Dividends per shareUHS Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6

5.3 Sustainability

  • UHS pays out 3.78% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of UHS is growing, but earnings are growing more, so the dividend growth is sustainable.
DP3.78%
EPS Next 2Y10.4%
EPS Next 3Y9.72%
UHS Yearly Income VS Free CF VS DividendUHS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
UHS Dividend Payout.UHS Dividend Payout, showing the Payout Ratio.UHS Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

UNIVERSAL HEALTH SERVICES-B

NYSE:UHS (2/26/2026, 1:08:38 PM)

205.43

-25.3 (-10.97%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-25
Earnings (Next)04-27
Inst Owners98.09%
Inst Owner Change-1.69%
Ins Owners5.68%
Ins Owner Change2.62%
Market Cap12.84B
Revenue(TTM)N/A
Net Income(TTM)1.38B
Analysts70.37
Price Target252.08 (22.71%)
Short Float %3.87%
Short Ratio2.81
Dividend
Industry RankSector Rank
Dividend Yield 0.35%
Yearly Dividend0.81
Dividend Growth(5Y)6.27%
DP3.78%
Div Incr Years0
Div Non Decr Years4
Ex-Date03-02
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.07%
Min EPS beat(2)7.62%
Max EPS beat(2)16.52%
EPS beat(4)4
Avg EPS beat(4)12.73%
Min EPS beat(4)7.62%
Max EPS beat(4)16.65%
EPS beat(8)8
Avg EPS beat(8)13.14%
EPS beat(12)12
Avg EPS beat(12)10.1%
EPS beat(16)14
Avg EPS beat(16)6.62%
Revenue beat(2)2
Avg Revenue beat(2)1.31%
Min Revenue beat(2)0.18%
Max Revenue beat(2)2.44%
Revenue beat(4)3
Avg Revenue beat(4)0.48%
Min Revenue beat(4)-2.29%
Max Revenue beat(4)2.44%
Revenue beat(8)7
Avg Revenue beat(8)0.45%
Revenue beat(12)9
Avg Revenue beat(12)0.29%
Revenue beat(16)13
Avg Revenue beat(16)0.58%
PT rev (1m)-0.95%
PT rev (3m)1.14%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.07%
EPS NY rev (1m)0%
EPS NY rev (3m)2.76%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.07%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.46%
Valuation
Industry RankSector Rank
PE 9.44
Fwd PE 8.65
P/S 0.76
P/FCF 13.26
P/OCF 6.59
P/B 1.79
P/tB 4.04
EV/EBITDA 7.44
EPS(TTM)21.76
EY10.59%
EPS(NY)23.75
Fwd EY11.56%
FCF(TTM)15.5
FCFY7.54%
OCF(TTM)31.18
OCFY15.18%
SpS271.97
BVpS114.75
TBVpS50.9
PEG (NY)1.03
PEG (5Y)0.66
Graham Number237.03
Profitability
Industry RankSector Rank
ROA 8.96%
ROE 19.18%
ROCE 16%
ROIC 12.33%
ROICexc 12.44%
ROICexgc 18.59%
OM 11.47%
PM (TTM) 8.09%
GM N/A
FCFM 5.7%
ROA(3y)6.01%
ROA(5y)6.51%
ROE(3y)13.4%
ROE(5y)14.27%
ROIC(3y)8.28%
ROIC(5y)8.76%
ROICexc(3y)8.36%
ROICexc(5y)9.07%
ROICexgc(3y)12.5%
ROICexgc(5y)14.04%
ROCE(3y)10.74%
ROCE(5y)11.37%
ROICexgc growth 3Y1.9%
ROICexgc growth 5Y0.81%
ROICexc growth 3Y3.79%
ROICexc growth 5Y2.74%
OM growth 3Y-0.49%
OM growth 5Y-0.12%
PM growth 3Y-2.68%
PM growth 5Y0.2%
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover1.11
Health
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 4.84
Debt/EBITDA 1.55
Cap/Depr 162.72%
Cap/Sales 5.77%
Interest Coverage 15.36
Cash Conversion 76.35%
Profit Quality 70.41%
Current Ratio 1.03
Quick Ratio 0.96
Altman-Z 3.24
F-Score8
WACC7.62%
ROIC/WACC1.62
Cap/Depr(3y)139.45%
Cap/Depr(5y)144.53%
Cap/Sales(3y)5.55%
Cap/Sales(5y)5.95%
Profit Quality(3y)70.11%
Profit Quality(5y)77.19%
High Growth Momentum
Growth
EPS 1Y (TTM)30.77%
EPS 3Y29.98%
EPS 5Y14.35%
EPS Q2Q%19.51%
EPS Next Y9.16%
EPS Next 2Y10.4%
EPS Next 3Y9.72%
EPS Next 5Y10.25%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%9.05%
Revenue Next Year4.96%
Revenue Next 2Y5.09%
Revenue Next 3Y3.5%
Revenue Next 5Y3.51%
EBIT growth 1Y26.53%
EBIT growth 3Y7.25%
EBIT growth 5Y6.7%
EBIT Next Year60.86%
EBIT Next 3Y20.8%
EBIT Next 5YN/A
FCF growth 1Y135.27%
FCF growth 3Y242.18%
FCF growth 5Y7.48%
OCF growth 1Y75.09%
OCF growth 3Y32.75%
OCF growth 5Y7.52%

UNIVERSAL HEALTH SERVICES-B / UHS FAQ

What is the fundamental rating for UHS stock?

ChartMill assigns a fundamental rating of 6 / 10 to UHS.


Can you provide the valuation status for UNIVERSAL HEALTH SERVICES-B?

ChartMill assigns a valuation rating of 8 / 10 to UNIVERSAL HEALTH SERVICES-B (UHS). This can be considered as Undervalued.


What is the profitability of UHS stock?

UNIVERSAL HEALTH SERVICES-B (UHS) has a profitability rating of 7 / 10.


What is the financial health of UNIVERSAL HEALTH SERVICES-B (UHS) stock?

The financial health rating of UNIVERSAL HEALTH SERVICES-B (UHS) is 5 / 10.


How sustainable is the dividend of UNIVERSAL HEALTH SERVICES-B (UHS) stock?

The dividend rating of UNIVERSAL HEALTH SERVICES-B (UHS) is 5 / 10 and the dividend payout ratio is 3.78%.